Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 1
2007 7
2008 17
2009 9
2010 12
2011 11
2012 11
2013 5
2014 1
2016 1
2020 3
2021 8
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Management of Takayasu arteritis.
Misra DP, Singh K, Rathore U, Kavadichanda CG, Ora M, Jain N, Agarwal V. Misra DP, et al. Best Pract Res Clin Rheumatol. 2023 Mar;37(1):101826. doi: 10.1016/j.berh.2023.101826. Epub 2023 May 26. Best Pract Res Clin Rheumatol. 2023. PMID: 37246052 Review.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R… See abstract for full author list ➔ Klionsky DJ, et al. Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8. Autophagy. 2021. PMID: 33634751 Free PMC article.
Renal involvement in Sjogren's syndrome: predictors and impact on patient outcomes.
Chatterjee R, Balakrishnan A, Kharbanda R, Rathore U, Gupta L, Misra DP, Agarwal V, Aggarwal A, Lawrence A. Chatterjee R, et al. Rheumatol Int. 2023 Jul;43(7):1297-1306. doi: 10.1007/s00296-022-05242-w. Epub 2023 Jan 18. Rheumatol Int. 2023. PMID: 36650312 Review.
Renal disease in primary Sjogren's Syndrome(pSS) occurs as tubulointerstitial nephritis(TIN) or glomerulonephritis(GN). ...Patients with nephritis had worse event-free survival.Our cohort had a younger age of onset of Sjogren's syndrome and a higher prevalence of ne …
Renal disease in primary Sjogren's Syndrome(pSS) occurs as tubulointerstitial nephritis(TIN) or glomerulonephritis(GN). ...Patients w …
Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence.
Suri JS, Puvvula A, Majhail M, Biswas M, Jamthikar AD, Saba L, Faa G, Singh IM, Oberleitner R, Turk M, Srivastava S, Chadha PS, Suri HS, Johri AM, Nambi V, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Bit A, Pareek G, Miner M, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Kolluri R, Teji J, Porcu M, Al-Maini M, Agbakoba A, Sockalingam M, Sexena A, Nicolaides A, Sharma A, Rathore V, Viswanathan V, Naidu S, Bhatt DL. Suri JS, et al. Rev Cardiovasc Med. 2020 Dec 30;21(4):541-560. doi: 10.31083/j.rcm.2020.04.236. Rev Cardiovasc Med. 2020. PMID: 33387999 Free article. Review.
Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis.
Misra DP, Rathore U, Kopp CR, Patro P, Agarwal V, Sharma A. Misra DP, et al. Clin Rheumatol. 2022 Dec;41(12):3601-3613. doi: 10.1007/s10067-022-06318-5. Epub 2022 Aug 5. Clin Rheumatol. 2022. PMID: 35927524 Review.
Meta-analysis of 263 pediatric-onset and 981 adult-onset TAK suggested that constitutional features (fever, and in subgroup analyses, weight loss), hypertension, headache, and sinister features of cardiomyopathy, elevated serum creatinine, and abdominal pain were more frequent in …
Meta-analysis of 263 pediatric-onset and 981 adult-onset TAK suggested that constitutional features (fever, and in subgroup analyses, weight …
Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.
Tomelleri A, Padoan R, Kavadichanda CG, Jose A, Singh K, Iorio L, Rathore U, Rinaldi E, Baldissera E, Agarwal V, Dagna L, Campochiaro C, Misra DP. Tomelleri A, et al. Rheumatology (Oxford). 2023 Oct 3;62(10):3427-3432. doi: 10.1093/rheumatology/kead161. Rheumatology (Oxford). 2023. PMID: 37018125
OBJECTIVES: The present study validates the 2022 ACR/European Alliance of Associations for Rheumatology (EULAR) classification criteria for Takayasu's arteritis (TAK), compared with the 1990 ACR TAK classification criteria. ...
OBJECTIVES: The present study validates the 2022 ACR/European Alliance of Associations for Rheumatology (EULAR) classification criteria for …
Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review.
Munjral S, Ahluwalia P, Jamthikar AD, Puvvula A, Saba L, Faa G, Singh IM, Chadha PS, Turk M, Johri AM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra P, Agarwal V, Kitas GD, Kolluri R, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Sharma A, Rathore V, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Omerzu T, Naidu S, Nicolaides A, Suri JS. Munjral S, et al. Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1312-1339. doi: 10.52586/5026. Front Biosci (Landmark Ed). 2021. PMID: 34856770 Free article. Review.
Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report.
Khanna NN, Maindarkar M, Puvvula A, Paul S, Bhagawati M, Ahluwalia P, Ruzsa Z, Sharma A, Munjral S, Kolluri R, Krishnan PR, Singh IM, Laird JR, Fatemi M, Alizad A, Dhanjil SK, Saba L, Balestrieri A, Faa G, Paraskevas KI, Misra DP, Agarwal V, Sharma A, Teji J, Al-Maini M, Nicolaides A, Rathore V, Naidu S, Liblik K, Johri AM, Turk M, Sobel DW, Pareek G, Miner M, Viskovic K, Tsoulfas G, Protogerou AD, Mavrogeni S, Kitas GD, Fouda MM, Kalra MK, Suri JS. Khanna NN, et al. J Cardiovasc Dev Dis. 2022 Aug 15;9(8):268. doi: 10.3390/jcdd9080268. J Cardiovasc Dev Dis. 2022. PMID: 36005433 Free PMC article. Review.
Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson's Disease Affected by COVID-19: A Narrative Review.
Suri JS, Maindarkar MA, Paul S, Ahluwalia P, Bhagawati M, Saba L, Faa G, Saxena S, Singh IM, Chadha PS, Turk M, Johri A, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou AD, Misra DP, Agarwal V, Kitas GD, Kolluri R, Teji JS, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Sharma A, Rathore V, Fatemi M, Alizad A, Krishnan PR, Omerzu T, Naidu S, Nicolaides A, Paraskevas KI, Kalra M, Ruzsa Z, Fouda MM. Suri JS, et al. Diagnostics (Basel). 2022 Jun 24;12(7):1543. doi: 10.3390/diagnostics12071543. Diagnostics (Basel). 2022. PMID: 35885449 Free PMC article. Review.
Background and Motivation: Parkinson's disease (PD) is one of the most serious, non-curable, and expensive to treat. ...
Background and Motivation: Parkinson's disease (PD) is one of the most serious, non-curable, and expensive to treat. ...
95 results